Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Talc Thoracoscopy vs Talc Slurry for Malignant Pleural Effusion
NCT00002622Phase 3Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Dec 1994
- Primary completion
- Mar 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of talc in malignant pleural effusion (MPE) (2 arms), sponsored by Cancer and Leukemia Group B. Primary endpoints: Successful pleurodesis at 30 days and Cost and cost effectiveness at 30 days. Started Dec 1994; status: completed.
02
Drugs
talc
03
Conditions
malignant pleural effusion (MPE)
Beyond the preview
Go deeper on NCT00002622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002622.